Common genetic variants and response to atrial fibrillation ablation

Circulation: Arrhythmia and Electrophysiology

Volumn 8, Issue 2, 2015, Pages 296-302

  Shoemaker, M Benjamin ^a   Bollmann, Andreas ^b   Lubitz, Steven A ^c   Ueberham, Laura ^b   Saini, Harsimran ^c   Montgomery, Jay ^a   Edwards, Todd ^a   Yoneda, Zachary ^a   Sinner, Moritz F ^d   Arya, Arash ^b   Sommer, Philipp ^b   Delaney, Jessica ^a   Goyal, Sandeep K ^a   Saavedra, Pablo ^a   Kanagasundram, Arvindh ^a   Whalen, S Patrick ^a   Roden, Dan M ^a   Hindricks, Gerhard ^b   Ellis, Christopher R ^a   Ellinor, Patrick T ^c   Darbar, Dawood ^a   Husser, Daniela ^b   more..

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

ablation techniques; atrial fibrillation; genomics

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CATHETER ABLATION; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME 4Q; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT RESPONSE; ADVERSE EFFECTS; ATRIAL FLUTTER; CHI SQUARE DISTRIBUTION; CHROMOSOME 1; CHROMOSOME 16; CHROMOSOME 4; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GERMANY; META ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK FACTOR; TACHYCARDIA, SUPRAVENTRICULAR; TIME; TREATMENT OUTCOME; UNITED STATES;

AGED; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BOSTON; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; TENNESSEE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84937573270     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.114.001909     Document Type: Article

References (16)

1. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042-1046. doi: 10.1161/01. CIR.0000140263.20897.42.
2. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666. doi: 10.1056/NEJM199809033391003.
3. Kobza R, Hindricks G, Tanner H, Schirdewahn P, Dorszewski A, Piorkowski C, Gerds-Li JH, Kottkamp H. Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. Heart Rhythm. 2004;1:676-683. doi: 10.1016/j.hrthm.2004.08.009.
4. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9:632-696.e21. doi: 10.1016/j.hrthm.2011.12.016.
5. Husser D, Adams V, Piorkowski C, Hindricks G, Bollmann A. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2010;55:747-753. doi: 10.1016/j.jacc.2009.11.041.
6. Benjamin Shoemaker M, Muhammad R, Parvez B, White BW, Streur M, Song Y, Stubblefield T, Kucera G, Blair M, Rytlewski J, Parvathaneni S, Nagarakanti R, Saavedra P, Ellis CR, Patrick Whalen S, Roden DM, Darbar R D. Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation. Heart Rhythm. 2013;10:394-400. doi: 10.1016/j.hrthm.2012.11.012.
7. Alderborn A, Kristofferson A, Hammerling U. Determination of singlenucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res. 2000;10:1249-1258.
8. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd ed. London, United Kingdom: BMJ; 2001.
9. Lubitz SA, Sinner MF, Lunetta KL, Makino S, Pfeufer A, Rahman R, Veltman CE, Barnard J, Bis JC, Danik SP, Sonni A, Shea MA, Del Monte F, Perz S, Müller M, Peters A, Greenberg SM, Furie KL, van Noord C, Boerwinkle E, Stricker BH, Witteman J, Smith JD, Chung MK, Heckbert SR, Benjamin EJ, Rosand J, Arking DE, Alonso A, Kaäb S, Ellinor PT. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation. 2010;122:976-984. doi: 10.1161/CIRCULATIONAHA.109.886440.
10. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190-2191. doi: 10.1093/bioinformatics/btq340.
11. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, Jonasdottir A, Baker A, Thorleifsson G, Kristjansson K, Palsson A, Blondal T, Sulem P, Backman VM, Hardarson GA, Palsdottir E, Helgason A, Sigurjonsdottir R, Sverrisson JT, Kostulas K, Ng MC, Baum L, So WY, Wong KS, Chan JC, Furie KL, Greenberg SM, Sale M, Kelly P, MacRae CA, Smith EE, Rosand J, Hillert J, Ma RC, Ellinor PT, Thorgeirsson G, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007;448:353-357. doi: 10.1038/nature06007.
12. Kirchhof P, Kahr PC, Kaese S, Piccini I, Vokshi I, Scheld HH, Rotering H, Fortmueller L, Laakmann S, Verheule S, Schotten U, Fabritz L, Brown NA. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ Cardiovasc Genet. 2011;4:123-133. doi: 10.1161/CIRCGENETICS.110.958058.
13. Chinchilla A, Daimi H, Lozano-Velasco E, Dominguez JN, Caballero R, Delpón E, Tamargo J, Cinca J, Hove-Madsen L, Aranega AE, Franco D. PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet. 2011;4:269-279. doi: 10.1161/CIRCGENETICS.110.958116.
14. Mommersteeg MT, Brown NA, Prall OW, de Gier-de Vries C, Harvey RP, Moorman AF, Christoffels VM. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res. 2007;101:902-909. doi: 10.1161/CIRCRESAHA.107.161182.
15. Tao Y, Zhang M, Li L, Bai Y, Zhou Y, Moon AM, Kaminski HJ, Martin JF. Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes. Circ Cardiovasc Genet. 2014;7:23-32. doi: 10.1161/CIRCGENETICS.113.000259.
16. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol. 2012;60:628-636. doi: 10.1016/j.jacc.2012.05.022.